Respiratory

Pulmonary hypertension is a progressive and potentially fatal condition that can go undetected until it reaches advanced stages. A groundbreaking study presented at the CHEST Annual Meeting 2024 introduces a multimodal fusion model (MMF-PH) that incorporates AI

Findings from two Phase 3 clinical trials, BOREAS and NOTUS, revealed that dupilumab, a monoclonal antibody targeting key drivers of type 2 inflammation, improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD)

A new study presented at the CHEST Annual Meeting 2024 highlights the growing disparity in mortality rates for women with chronic obstructive pulmonary disease (COPD), especially those in rural areas.

Hospital stays lead to worsening fatigue and shortness of breath in patients with idiopathic pulmonary fibrosis (IPF) according to a new study presented at the CHEST 2024 Annual Meeting.

A digital health program, mPATH-Lung, has been shown to significantly improves lung cancer screening (LCS) rates among high-risk individuals.

A new study presented at the CHEST Annual Meeting 2024 highlighted the success of a new clinic aimed at improving palliative care access.

Accelerating the global decline in tobacco smoking could significantly increase life expectancy and prevent millions of premature deaths by 2050, according to new research.

A new study reveals that over half of healthy U.S. infants contract respiratory syncytial virus in their first year, with 44.1% developing lower respiratory tract infections.